Skip navigation

Current DateTime: 10:08:39 12 Nov 2009
LinksList Documentid: 24355697

FEATURED QUIZZES


Current DateTime: 10:08:39 12 Nov 2009
LinksList Documentid: 33793611
  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?

  • The Many Myths of Coca-Cola

      Can you tell which statements are true, and which ones are just rumors?

  • Think You Understand Markets?

      We've selected some questions from the Financial Industry Regulatory Authority's test of investor knowledge. See how you do ...


Current DateTime: 10:08:39 12 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
Charts Predict: Trouble for Chinese Stocks
By: CNBC.com | 12 Jan 2009 | 05:26 AM ET
Text Size

Invest in the dollar and Syngenta, but steer clear of Chinese stocks and corporate bonds, Robin Griffiths, technical strategist at Cazenove Capital said Monday.

The greenback is going up again, according to Griffiths. The target for the dollar index is 100, he added.

"The dollar trade weight will go to 100, which means against most other currencies, it's got 15 percent or so upside," Griffiths told CNBC.

"(Two-thousand-and-nine) It can easily be worse than last year… you need money in the bank. And the money better be the right type of money or you lose. And the dollar is the right type of money while the planet is deleveraging," he said.

The Shanghai Composite bottomed in September last year, ahead of most other markets, but has failed to correct appropriately, Griffiths noted.

"In the short-term, China may not be the solution to the problem. It might be the problem," he said.

"I don't see any early recovery," he said. "I think we should be risk averse and hold on to what we've got, which is better than trying to make a whole lot more money."

In addition, agriculture company Syngenta should benefit from the "foul" weather 2009 will experience, he said.

"You're going to find Syngenta and other companies in this space are on a jolly good wicket and if you've got to own some equities, this is the sort of franchise that you need to stick with," he said.

And investors shouldn't buy corporate bonds, since it is a "risky fad" and nobody knows which bond will default, Griffiths said.

"On a relative basis the bond market is) the right place to be. But there's still risks and I'd rather stick with proper money," he said.

© 2009 CNBC.com
Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
  • They may have wrecked their companies or saved our economy. Tell us what you think.
  • Big pharma embraces social media, but how much should a tightly regulated sector say on Facebook or Twitter?
  • A European dating site finds lovelorn singles from one country to be consistently uglier. Which is it?
  • Contributor David Pogue looks at two of the latest efforts to perfect the digital pocket camera.
  • PepsiCo is ramping up its onsite health facilities for workers.
ADD COMMENTS
Remaining characters


Current DateTime: 02:33:17 12 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 11:27:47 12 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 05:29:42 12 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:00:12 12 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters